NOV.DE · NOVO-NORDISK AS B DK 0,1
Germany · RS rating 31 · As of 2026-10-14
| Price | 34.37 EUR |
|---|---|
| 1-day change | +0.2% |
| RS rating (overall / 1M / 3M / 12M) | 31 / 21 / 18 / 49 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 25 / 17 / 24 |
| Industry group (rank) | Medical-Ethical Drugs (–) |
| EPS growth Q/Q | -56.5% |
| Sales growth Q/Q | -18.9% |
| Distance from 52-week high | +36.0% |
| Market cap (USD) | $169.1B |